CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.

González de Aledo M, González-Bardanca M, Blasco L, Pacios O, Bleriot I, Fernández-García L, Fernández-Quejo M, López M, Bou G, Tomás M

Open source

DOI
10.3390/antibiotics10070756
Published
2021 Jun 22
Container
Antibiotics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics10070756,
  title = {CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.},
  author = {González de Aledo M and González-Bardanca M and Blasco L and Pacios O and Bleriot I and Fernández-García L and Fernández-Quejo M and López M and Bou G and Tomás M},
  year = {2021},
  journal = {Antibiotics (Basel, Switzerland)},
  doi = {10.3390/antibiotics10070756},
  url = {https://doi.org/10.3390/antibiotics10070756}
}

RIS

TY  - JOUR
TI  - CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.
AU  - González de Aledo M
AU  - González-Bardanca M
AU  - Blasco L
AU  - Pacios O
AU  - Bleriot I
AU  - Fernández-García L
AU  - Fernández-Quejo M
AU  - López M
AU  - Bou G
AU  - Tomás M
PY  - 2021
JO  - Antibiotics (Basel, Switzerland)
DO  - 10.3390/antibiotics10070756
UR  - https://doi.org/10.3390/antibiotics10070756
ER  - 

APA

M, G. D. A., M, G., L, B., O, P., I, B., L, F., M, F., M, L., G, B., & M, T. (2021). CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.. Antibiotics (Basel, Switzerland). https://doi.org/10.3390/antibiotics10070756

Source records